ALL vs SYRE · P/E 4.9, rev $18.60B vs $7.60B cap
The Allstate Corporation (ALL) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the ALL and SYRE stock pages for the full models.
Not investment advice.